|
|
Volumn 49, Issue 2, 2001, Pages 234-235
|
|
Association between oxybutynin and neuropsychiatric adverse effects not confirmed in daily practice [4]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZODIAZEPINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
FLAVOXATE;
NEUROLEPTIC AGENT;
OXYBUTYNIN;
SPASMOLYTIC AGENT;
ADULT;
AGED;
DETRUSOR DYSSYNERGIA;
DISEASE ASSOCIATION;
DRUG INDUCED DISEASE;
GERIATRIC PATIENT;
HUMAN;
LETTER;
MAJOR CLINICAL STUDY;
MENTAL DISEASE;
PRESCRIPTION;
PSYCHOSIS;
AGED;
AGED, 80 AND OVER;
ANTIPSYCHOTIC AGENTS;
CHOLINERGIC ANTAGONISTS;
DRUG UTILIZATION;
FLAVOXATE;
HUMANS;
MANDELIC ACIDS;
MENTAL DISORDERS;
MIDDLE AGED;
NERVOUS SYSTEM DISEASES;
NETHERLANDS;
PARASYMPATHOLYTICS;
PHARMACIES;
PRESCRIPTIONS, DRUG;
RETROSPECTIVE STUDIES;
RISK FACTORS;
URINATION DISORDERS;
|
|
EID: 0035090089
PISSN: 00028614
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1532-5415.2001.04949.x Document Type: Letter |
|
Times cited : (11)
|
|
References (10)
|
